US Stock MarketDetailed Quotes

Myriad Genetics (MYGN)

Watchlist
  • 5.080
  • +0.080+1.60%
Close Apr 17 16:00 ET
  • 5.070
  • -0.010-0.20%
Post 17:58 ET
479.77MMarket Cap-1.29P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Myriad Genetics (MYGN) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/FY
Stock NameRevenueRatio
Hereditary Cancer372.4M45.17%
Prenatal186.3M22.60%
Mental Health144.1M17.48%
Tumor Profiling121.7M14.76%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States (U.S.)768M93.15%
Rest of world (RoW)56.5M6.85%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -